Canada’s Macular Degeneration Treatment Controversy
Off-label use of the cancer drug Avastin
Having known friends experiencing macular degeneration (AMD), a medical condition that can lead to blindness, my attention was caught by news of a growing trans-Atlantic controversy regarding an off-label use of the cancer drug Avastin, which has not received formal approval as an AMD treatment in Canada, the European Union, England, and the United States.
Read Full Article...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy